Cellvera Global Holdings

Cellvera is a biopharmaceutical company dedicated to discovering, developing, and commercializing antiviral therapies to combat life-threatening viral diseases. The company's flagship product is Avigan (favipiravir), a broad-spectrum oral antiviral for which it holds exclusive rights in most global territories outside of Japan, China, and Russia. Cellvera focuses on addressing global health crises, including the COVID-19 pandemic and seasonal influenza, by leveraging strategic manufacturing and distribution partnerships. The company is positioned as a key player in the infectious disease space, aiming to provide accessible treatments for RNA-based viral infections. Through its collaboration with Fujifilm Toyama Chemical, Cellvera works to scale the production and clinical validation of its antiviral portfolio.